International Journal of Cancer Research & Therapy(IJCRT)
ISSN: 2476-2377 | DOI: 10.33140/IJCRT
Impact Factor: 1.382
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Pre operative Early Hormonotherapy the New Gold Standard for Operable Luminal Breast Cancer
Abstract
Vasco Fonseca, Zacharoula Sidiropoulou
Even though it is not yet a universally accepted, in our view, the best clinical practice in the case of operable luminal breast cancer is to begin systemic neoadjuvant hormonotherapy (HT) immediately after histologic diagnosis for the majority of patients. This strategy does not apply to patients with an indication for neoadjuvant chemotherapy.